← FDA DRUG APPROVALS

FDA ANDA · ANDA076582

FENOLDOPAM MESYLATE

Sponsor: HIKMA

APPLICATION
ANDA076582
TYPE
ANDA
ORIGINAL APPROVAL
2004-10-12
LATEST ACTION
2011-03-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FENOLDOPAM MESYLATEDiscontinued
FENOLDOPAM MESYLATE EQ 10MG BASE/ML · INJECTABLE · INJECTION

Approval history

2011-03-30Labeling · Supplement 7AP
2004-10-12OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →